Acetaldehyde, a product of ethanol metabolism, has been implicated in a number of actions of alcohol (1) and is notable for its ability to bind covalently to erythrocyte and plasma proteins and to subcellular organelles (2) (3) (4) (5) (6) (7) . However, the identification and quantification of acetaldehyde-protein condensates have been hampered due to the small amounts of these condensates that are formed at acetaldehyde concentrations that occur following alcohol consumption (5) . Thus, identification of adduct formation has relied on the use of radioactive acetaldehyde.
Studies by Stevens et al. (2) , Donohue et al. (3) , and Tuma et al. (4) have shown that acetaldehyde binding to proteins leads to the formation of both stable and unstable adducts. The latter, postulated to be Schiff bases (2) (3) (4) , can be stabilized by various reducing agents, such as sodium borohydride, sodium cyanoborohydride, or ascorbate (2) (3) (4) . Depending on the binding conditions, stable acetaldehyde adducts to bovine serum albumin and to human hemoglobin, prepared at concentrations of 200-300 AuM acetaldehyde, comprise 15-70% of the total adducts formed (2-4). Stable and stabilized adducts are resistant to conditions such as acid precipitation, gel filtration, and extensive dialysis (2) (3) (4) . Studies by Stevens et al. (2) have shown that three amino acid residues in hemoglobin (lysine, tyrosine, and valine) can bind acetaldehyde and can be stabilized by sodium borohydride.
Spontaneous reduction and physiological reducing agents (e.g., ascorbate) have been suggested to mediate the formation of stable adducts similar to exogenous reducing agents (4) . In addition, cross-linking of proteins has been shown to occur at high concentrations of acetaldehyde (8) . Products formed at high concentrations of acetaldehyde have been reported not to be reducible by sodium borohydride (9) .
We hypothesize that molecular structures formed in acetaldehyde-protein adducts may be recognized as foreign by the immune system, resulting in the generation of antibodies. Such antibodies could provide a basis for quantification of unlabeled condensates in erythrocytes and plasma proteins, which could in turn provide a cumulative record of acetaldehyde load, reflecting recent chronic alcohol consumption by an individual and analogous to the use of glycosylated hemoglobin as an index of mean blood glucose levels over a period of several weeks (10) (11) (12) .
The detection of acetaldehyde adducts is also of interest in the study of the pathogenesis of alcohol-induced liver injury, since covalent binding of acetaldehyde to macromolecules might underlie alcoholic liver damage (13) . Should such condensates be immunogenic, their presence on the surface of hepatocytes could lead to liver cell injury mediated by the immune surveillance system. In addition, circulating immune (antigen-antibody) complexes might mediate observed organic pathology induced by ethanol in tissues other than the liver.
In this report, we describe studies showing that (i) antibodies can be generated against epitopes containing the acetaldehyde residue in acetaldehyde-protein condensates; (ii) these antibodies are able to react with both stable and stabilized condensates formed at acetaldehyde concentrations comparable to those present in the blood of alcoholics; (iii) the antibodies can react independently of the nature of the macromolecule binding the acetaldehyde moiety; and (iv) chronic alcohol ingestion per se leads to the generation of antibodies directed against acetaldehyde-modified proteins, thus suggesting that such condensates are formed in vivo.
Portions of this work have been previously presented (14) §. Plasma protein conjugates. Saturated ammonium sulfate (27 ml), pH 7.1, was added to 9 ml of human plasma and mixed for 2 hr at 4°C. The precipitate containing plasma proteins, of which albumin is the main constituent, was centrifuged at 10,000 x g for 20 min. The pellet was dissolved in 18 ml of PBS and dialyzed at 4°C against 1 liter of half-strength PBS. Final protein concentration was brought to 16 mg/ml, and 5 ml of the solution was added to 5 ml of 480 mM acetaldehyde in PBS. The reaction was allowed to proceed for 60 min at 20°C, and 700 mg of NaCNBH3 dissolved in 2 ml of PBS was added. After 45 min, the mixture was dialyzed at 4°C against 1 liter of PBS. In parallel experiments with NaCNB3H3, incorporation of acetaldehyde was estimated to be 726 nmol/mg of protein.
MATERIALS AND METHODS
Hemocyanin conjugates. Purified hemocyanin from keyhole limpet (Calbiochem) in saturated ammonium sulfate at a concentration of 10 mg/ml was dialyzed for 4 days at 4°C against 4 liters of 5% (wt/vol) Na2CO3 and for one day against PBS adjusted to pH 8.7 . Two milliliters of keyhole limpet hemocyanin (5 mg/ml) was mixed with 2 ml of 480 mM acetaldehyde at 20°C. After 60 min, 63 mg of NaCNBH3 in 0.5 ml of H20 were added. The mixture was allowed to stand for 3 hr at 20°C and then dialyzed at 4°C against PBS, pH 9.5.
Preparation of Protein-Acetaldehyde Conjugates at Low Acetaldehyde Concentrations. Poly(amino acid) conjugates. Solutions of poly-(L-lysine) (Sigma), poly-(L-tyrosine) (Sigma) and poly-(L-valine) (Sigma) at concentrations of 0.5 mg/ml in PBS were placed in dialysis bags (2.5 ml), and immersed for 70 hr in 500 ml of PBS containing either 0, 100 ,tM, 1 mM, or 10 mM acetaldehyde in the presence or absence of 10 (17) .
RESULTS
Immunization with the heavily conjugated erythrocyte protein-acetaldehyde condensate yielded antibodies that strongly reacted with plasma protein-acetaldehyde condensate but not with control plasma proteins (Fig. 1) . Similarly, immunization with plasma protein-acetaldehyde condensate yielded antibodies that strongly reacted with erythrocyte proteinacetaldehyde condensate but not with the unmodified erythrocyte proteins (Fig. 2) . The affinity-purified immunoglob- ulins were further tested for reactivity against erythrocyte proteins modified at lower acetaldehyde concentrations including those of 20 ,uM and 100 AM, which exist in the blood of alcoholics (15) . Fig. 3 shows that the antibodies indeed recognized erythrocyte protein-acetaldehyde condensates prepared at these concentrations. Fig. 4 shows that the antibodies recognized the erythrocyte protein-acetaldehyde condensates both in their stable and cyanoborohydridestabilized forms, although the latter were more reactive.
When tested against poly-(L-lysine), poly-(L-tyrosine), and poly-(L-valine) condensates, the antibodies recognized only the poly-(L-lysine)-acetaldehyde adducts. The immunoreactivity toward stable poly-(L-lysine) adducts, in the absence of sodium cyanoborohydride, is as follows (mean OD at 405 nm + SE): control polylysine, 0.150 ± 0.009; polylysine condensate with 100 AM acetaldehyde, 0.296 ± 0.040 (P < 0.02); 1 mM acetaldehyde, 0.348 ± 0.031 (P < 0.001); 10 mM acetaldehyde, 0.327 ± 0.039 (P < 0.005). In the presence of sodium cyanoborohydride, immunoreactivity was three times higher. At 10 mM acetaldehyde in the presence of 10 mM sodium cyanoborohydride, duplicate OD readings were 0.998 and 1.020. It should be noted that high backgrounds are expected in polylysine-coated wells, independently of the type and source of the antibodies (16) . No immunoreactivity was detected for either the stable or stabilized forms of poly-(L-tyrosine) and poly-(L-valine)-acetaldehyde condensates at concentrations up to 10 mM acetaldehyde. The above data suggest that the antibodies can recognize the molecular structure of the N-ethyllysine residue. When tested for inhibition of the immune reaction, 10 mM N-ethyllysine, the highest concentration tested, decreased the ELISA readings by 20-25%. At 405 nm, control OD was 0.298 ± 0.025; 10 mM N-ethyllysine OD was 0.232 ± 0.047 (P < 0.05); 10 mM lysine OD was 0.284 ± 0.020 (not significant); (n = 4).
The above results indicated that immunoglobulins against acetaldehyde-containing epitopes in proteins can be generated independently of the protein carriers used for immunization, suggesting that an acetaldehyde-bound nonmammaHan protein (keyhole limpet hemocyanin) may also serve as an antigen. Fig. 5 shows that immunization with this condensate also generated antibodies against the plasma proteinacetaldehyde and erythrocyte-acetaldehyde condensates but not against their respective unmodified proteins.
Antibodies against the acetaldehyde-containing epitopes were also produced by an alternative approach. Specifically, lymphocytes in the spleen of erythrocyte protein-acetaldehyde immunized animals whose sera reacted both with erythrocyte proteins and with erythrocyte protein-acetaldehyde conjugate were hybridized with malignant myeloma cells. Out of420 wells with hybridoma growth tested, 30 wells produced immunoglobulins that strongly reacted with both the erythrocyte protein-acetaldehyde condensate and with plasma protein-acetaldehyde condensate. Of these, 16 clones were subsequently selected for further cultures. The relative affinity of immunoglobulins released by the hybridoma into the culture fluids was compared at different dilutions against both the erythrocyte protein-acetaldehyde conjugate (pre- pared at 1 mM acetaldehyde) as well as the control erythrocyte protein. As is evident in Fig. 6 , this approach also yields immunoglobulins that react preferentially with the acetaldehyde-containing epitope(s) in hemoglobin adducts as opposed to control hemoglobin: in four of the clones, the immunoglobulin affinity was at least 50 times higher for the erythrocyte protein-acetaldehyde condensate than for the control erythrocyte protein.
Antibody production against protein-acetaldehyde condensates was also induced by chronic administration of alcohol to C57BL mice-reputedly poor immunological responders (18) with a high preference for ethanol ingestion (19) . Plasma from alcohol-treated animals showed significantly higher (P < 0.03) immunoreactivity against erythrocyte protein-acetaldehyde condensates than that for control animals, as measured either by radioimmunoassay (Fig. 7) immunization with protein-acetaldehyde condensates can recognize small acetaldehyde-containing epitopes in macromolecules. To our knowledge, this would be the smallest molecular weight hapten for which antibodies have been raised. We have found that antibodies towards acetaldehydecontaining epitopes in proteins could be raised by immunizing with acetaldehyde conjugated to a carrier protein different from the one that is used for testing. Furthermore, similar results were obtained by hybridization and selection ofclones that preferentially recognize the acetaldehyde-conjugated protein rather than the unconjugated molecule.
Acetaldehyde can covalently bind to various proteins to form both stable and unstable adducts; valine, lysine, and tyrosine residues probably being the sites of reaction (2) . Our data suggest that the lysine-acetaldehyde adduct, likely comprising the N-ethyllysine residue, is immunologically recognized by the antibodies. However, we cannot discount the possibility that an intra-or intermolecular stabilization of the lysine-acetaldehyde Schiff base also occurred and was detected by the antibodies. On the other hand, the intermolecular stabilization possibility is less likely in view of the studies by Donohue et al. Protein-acetaldehyde adducts have been suggested as clinically useful markers for alcohol consumption (2) . Separation of a and p globins of hemoglobin would increase the capabilities for the detection of acetaldehyde conjugates, as the 8 chains bind acetaldehyde nine times more efficiently than the a chains (20) . A selective binding of acetaldehyde to some residues is also in agreement with studies by Jennett et al. (21) , who showed that the formation of stable adducts occurs preferentially for some specific lysine residues in the tubulin dimer molecule. Our observations should provide the basis for both the development of sensitive immunological assays to monitor recent alcohol consumption and for the study of the biology of acetaldehyde condensates in relation to organ pathology in alcoholism. These suggestions are further supProc. Natl. Acad. Sci. USA 83 (1986) 0 0 ported by the fact that the antibodies generated recognized spontaneously stable protein-acetaldehyde adducts formed in the absence of exogenous reducing agents at concentrations of acetaldehyde analogous to those found in the blood of alcoholics.
A number of studies have suggested that alcoholic liver disease may have an immunological component (22) (23) (24) (25) (26) (27) (28) (29) . Studies by Sorrell and Leevy (22) demonstrated that, in vitro, acetaldehyde (190 PM), at concentrations similar to those used in our study, is able to stimulate proliferation of lymphocytes obtained from patients with alcoholic hepatitis. Based on our findings, we suggest a possible mechanism for such lymphocyte proliferation, namely that acetaldehyde may have led to the formation of adducts, which in turn are recognized by immunoglobulins present in the membrane of lymphocytes, thus leading to lymphocyte proliferation. The present data can also account for the observation that sera of alcoholics, but not of controls, can induce cytotoxicity in hepatocytes isolated from animals pretreated in vivo with ethanol (25, 27) . The fact that such cytotoxicity was inhibited by pretreatment of the animals with 4-methylpyrazole and enhanced by disulfiram strongly suggests that acetaldehyde was implicated in this effect.
Several reports have suggested abnormalities of humoral immunity in alcoholic liver disease, resulting probably from excessive antigenic stimulation or heightened immune response (29) . The increased antigenic stimulation may be due to alcohol-induced changes. The fact that in our studies chronic alcohol administration per se triggered the production of circulating immunoglobulins against acetaldehydemodified proteins suggests that these condensation compounds also form in vivo following chronic alcohol consumption and subsequently can act as neoantigens.
